IBCP:NASDAQIndependent Bank Corporation Analysis
Data as of 2026-05-23 - not real-time
$33.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Independent Bank Corp. sits on a solid technical base, with the 20‑day SMA just above the 50‑day SMA and the price comfortably above the 200‑day SMA, while a bullish MACD crossover and a neutral RSI suggest momentum is intact. Valuation metrics reinforce a compelling case: the stock trades well below its DCF fair value and carries a P/E ratio markedly lower than the industry average, delivering an upside potential that exceeds eight percent.
The recent cash‑and‑stock acquisition of HCB Financial expands IBCP’s footprint in a high‑growth Michigan corridor, adding a catalyst for revenue expansion. Coupled with a 3.3% dividend yield, a modest payout ratio, low leverage and a respectable ROE, the fundamentals portray a resilient, dividend‑sustainable regional bank with attractive risk‑adjusted returns.
The recent cash‑and‑stock acquisition of HCB Financial expands IBCP’s footprint in a high‑growth Michigan corridor, adding a catalyst for revenue expansion. Coupled with a 3.3% dividend yield, a modest payout ratio, low leverage and a respectable ROE, the fundamentals portray a resilient, dividend‑sustainable regional bank with attractive risk‑adjusted returns.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup with SMA alignment and MACD signal
- Acquisition news providing near‑term earnings uplift
- Current price below both DCF and industry valuation benchmarks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth trajectory supported by expanded market presence
- Sustainable dividend yield with low payout ratio
- Undervalued relative to peers offering attractive upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong cash position and low beta indicating stability
- Long‑term dividend sustainability and solid ROE
- DCF‑based valuation gap suggesting enduring undervaluation
Key Metrics & Analysis
Financial Health
Revenue Growth9.70%
Profit Margin31.08%
P/E Ratio10.1
ROE14.28%
ROA1.28%
P/B Ratio1.4
Op. Cash Flow$48.3M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI52.4
Support$32.45
Resistance$34.59
MA 20$33.57
MA 50$33.56
MA 200$33.09
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$37.58
Target Price$36.70
Upside/Downside8.26%
GradeUndervalued
TypeBlend
Dividend Yield3.31%
Risk Assessment
Beta0.82
Volatility22.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.